COPD encompasses both extremes of weight. Obesity affects some 54% of patients in the U.S., but underweight is also an issue, affecting anywhere from 4% to 40% across populations, with ...

COPD rates are higher in rural communities than urban areas, the nonprofit said, and patients may lack easy access to hospitals and other resources.

Merck has agreed to a $10-billion buyout of Verona Pharma and its first-in-class, potential COPD blockbuster Ohtuvayre.

Verona Pharma’s stock soars toward a record after $10 billion buyout deal with Merck.

The FDA recently approved mepolizumab for treating adults with inadequately controlled COPD and an eosinophilic phenotype, marking the second biologic approved as an add-on maintenance treatment ...

Lung conditions, like asthma and chronic obstructive pulmonary disease, are more common in women than men.

With COPD, you can be at risk for serious complications that not only put your health in jeopardy, but also could be fatal. We'll share tips for preventing them.

Pharmaceutical giant Merck is buying Verona Pharma, a company that focuses on respiratory diseases, in an approximately $10 billion deal. The deal gives Merck access to Verona Pharma's new chronic ...

The deal gives Merck access to Verona Pharma’s new chronic obstructive pulmonary disease medication Ohtuvayre.

Learn about COPD medications, including bronchodilators, steroids, and combination treatments. Understand how they work, their side effects, and ways to manage COPD effectively.

Tezepelumab has received an FDA breakthrough therapy designation as a maintenance treatment for patients with moderate to very severe COPD characterized by an eosinophilic phenotype, according to ...